Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing
Shengping Hou1, Jian Qi, Dan Liao
1The First Affiliated Hospital of Chongqing Medical University, Chongqing Eye Institute, and Chongqing Key Laboratory of Ophthalmology, Chongqing, China.
Insights
High copy numbers of complement component C4A increase Behçet's disease risk by altering C4A expression and boosting interleukin-6. This finding clarifies a key factor in Behçet's disease pathogenesis.
Area of Science:
- Immunogenetics
- Inflammatory Diseases
- Complement System
Background:
- Complement component C4 (C4) copy number variations are linked to inflammatory conditions.
- The role of C4 copy number variations in Behçet's disease (BD) pathogenesis remains unclear.
Purpose of the Study:
- To investigate the association between C4 copy number variations and Behçet's disease.
- To explore the impact of C4 copy number variations on C4 expression and cytokine production in BD.
Main Methods:
- Real-time PCR was used to detect C4A and C4B copy number variations in 905 BD patients and controls.
- ELISA and real-time PCR assessed gene expression.
- Flow cytometry analyzed T cell activation, and ELISA measured cytokine levels, including IL-6.
Main Results:
- Significantly increased C4A copy number (>2 copies) was found in BD patients (P = 1.65 × 10(-7)).
- High C4A copy number correlated with increased C4A expression and elevated IL-6 production.
- C4A copy number variation was identified as an independent risk factor for BD, distinct from HLA-B51.
Conclusions:
- A high copy number of C4A is a risk factor for Behçet's disease.
- This risk is mediated through modulation of C4A expression and enhanced IL-6 production.
- Findings contribute to understanding the immunogenetic basis of Behçet's disease.
Objective:
Complement component C4 copy number variations are associated with various inflammatory diseases. This study was undertaken to investigate whether copy number variations of C4 are also involved in the pathogenesis of Behçet's disease (BD).
Methods:
Gene expression was examined by enzyme-linked immunosorbent assay (ELISA) or real-time polymerase chain reaction (PCR). Copy number variations of C4 isotypes (C4A and C4B) were detected by real-time PCR in 905 patients with BD, 205 patients with ankylosing spondylitis (AS) and acute anterior uveitis, and 1,238 controls. The activation of CD4+ T cells was analyzed by flow cytometry, and cytokine production was detected by ELISA.
Results:
Protein expression of total C4 in serum was significantly increased in patients with active BD compared with those with inactive BD or controls (Bonferroni corrected P [Pcorr ] = 1.64 × 10(-4) and Pcorr = 0.037, respectively), but not in patients with AS and acute anterior uveitis. Copy number variation analysis identified a significantly increased frequency of more than 2 copies of C4A in BD patients (P = 1.65 × 10(-7) , odds ratio [OR] 2.84). HLA-B51, which is located on the same chromosome as C4, showed a strong association with BD in the Han Chinese population (P = 8.90 × 10(-65) , OR 5.05), but logistic regression showed that C4A copy number variation was an independent risk factor for BD. A significantly increased expression of C4A was observed in the high copy number groups (>2 copies or 2 copies) versus the low copy number group (Pcorr = 0.019 and Pcorr = 0.044, respectively). Increased production of interleukin-6 (IL-6) was also observed in the high C4A copy number group (Pcorr = 0.037). No effect of C4 copy number variation on the expression of T cell activation markers was detected.
Conclusion:
Our findings indicate that a high copy number of C4A confers risk for BD by modulating the expression of C4A and enhancing IL-6 production.
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Complement System
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Crohn's Disease
Single Nucleotide Polymorphisms-SNPs
Histone Variants at the Centromere


